Filing Details
- Accession Number:
- 0001209191-18-038543
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-19 16:19:53
- Reporting Period:
- 2018-06-15
- Accepted Time:
- 2018-06-19 16:19:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1008848 | Acorda Therapeutics Inc | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197032 | F Ian Smith | 420 Saw Mill River Road Ardsley NY 10502 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-15 | 10,000 | $25.45 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-06-15 | 15,000 | $13.80 | 25,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-15 | 25,000 | $31.42 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Employee Stock Option | Disposition | 2018-06-15 | 10,000 | $0.00 | 10,000 | $25.45 |
| Common Stock | Non-Employee Stock Option | Disposition | 2018-06-15 | 15,000 | $0.00 | 15,000 | $13.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-06-22 | No | 4 | M | Direct | |
| 0 | 2027-05-31 | No | 4 | M | Direct |
Footnotes
- Exercises and sales pursuant to a 10b5-1 plan.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $31.15 to $31.55 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The shares subject to these options vested in installments and were fully vested on 6/22/2010.
- The shares subject to these options vested in installments and were fully vested on 5/31/2018.
Billionaire Hedge Funds
